If you liked this article you might like

Biogen Resolves Multiple Sclerosis Drug Dispute
Forward Pharma Shares Jump on Biogen License Agreement
Biogen Is a Takeover Target but Don't Ignore the Risks
Diarrhea Dings Xenoport Psoriasis Drug Study Results